The Impact of Patient Age and Socioeconomic Factors on Clinical Outcomes in Small Cell Lung Cancer (SCLC): A National Study

被引：0
|
作者：
Chen, R. [1 ]
Azzouqa, A. [1 ]
Manochakian, R. [1 ]
Ailawadhi, S. [1 ]
Lou, Y. [1 ]
机构：
[1] Mayo Clin Florida, Hematol & Oncol, Jacksonville, FL USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
small cell lung cancer; age; Socioeconomic factors;
D O I：
10.1016/j.jtho.2019.08.1121
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.12-08
引用
收藏
页码：S537 / S537
页数：1
相关论文
共 50 条
  • [31] Clinical Features and Prognostic Factors of Small Cell Lung Cancer: A Retrospective Study in 148 Patients
    Cai, Qian
    Luo, Hong-lan
    Gao, Xi-can
    Xiong, Chun-jin
    Tong, Fan
    Zhang, Rui-guang
    Hu, Yu
    Wu, Gang
    Dong, Xiao-rong
    JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2016, 36 (06) : 916 - 922
  • [32] Long-term survivors of small-cell lung cancer (SCLC): A French multicenter study
    Jacoulet, P
    Depierre, A
    Moro, D
    Riviere, A
    Milleron, B
    Quoix, E
    Ranfaing, E
    Anthoine, D
    Lafitte, JJ
    Lebeau, B
    Kleisbauer, JP
    Massin, F
    Fournel, P
    Zaegel, M
    Leclerc, JP
    Garnier, G
    Brambilla, E
    Capron, F
    ANNALS OF ONCOLOGY, 1997, 8 (10) : 1009 - 1014
  • [33] How do patient and hospital features influence outcomes in small-cell lung cancer in England?
    Rich, A. L.
    Tata, L. J.
    Free, C. M.
    Stanley, R. A.
    Peake, M. D.
    Baldwin, D. R.
    Hubbard, R. B.
    BRITISH JOURNAL OF CANCER, 2011, 105 (06) : 746 - 752
  • [34] GEMCITABINE IS AN ACTIVE NEW AGENT IN PREVIOUSLY UNTREATED EXTENSIVE SMALL-CELL LUNG-CANCER (SCLC) - A STUDY OF THE NATIONAL-CANCER-INSTITUTE-OF-CANADA CLINICAL-TRIALS GROUP
    CORMIER, Y
    EISENHAUER, E
    MULDAL, A
    GREGG, R
    AYOUB, J
    GOSS, G
    STEWART, D
    TARASOFF, P
    WONG, D
    ANNALS OF ONCOLOGY, 1994, 5 (03) : 283 - 285
  • [35] The frequency and impact of FGFR1 amplification on clinical outcomes in Korean patients with small cell lung cancer
    Park, Ji Soo
    Lee, Jae-Seok
    Kim, Eun Young
    Jung, Ji Ye
    Kim, Se Kyu
    Chang, Joon
    Kim, Dae Joon
    Lee, Chang Young
    Jung, Inkyung
    Kim, Joo Hang
    Kim, Hye Ryun
    Moon, Yong Wha
    Kim, Hyo Song
    Cho, Byoung Chul
    Shim, Hyo Sup
    LUNG CANCER, 2015, 88 (03) : 325 - 331
  • [36] Second-line chemotherapy for small-Cell Lung Cancer (SCLC)
    Kim, Young Hak
    Mishima, Michiaki
    CANCER TREATMENT REVIEWS, 2011, 37 (02) : 143 - 150
  • [37] Mediastinal emphysema and small cell lung cancer (SCLC): a case-report
    Libeer, C
    Verbeken, E
    De Wever, W
    Vansteenkiste, J
    Nackaerts, K
    LUNG CANCER, 2005, 47 (01) : 139 - 142
  • [38] Treatment and Outcomes of Patients with Limited-Stage Small-cell Lung Cancer in the Canadian SCLC Database (CASCADE)
    Moore, S. M.
    Zhan, L. J.
    Liu, G.
    Rittberg, R.
    Patel, D.
    Chowdhury, D.
    Leung, B.
    Cheng, S.
    Mckinnon, M.
    Khan, K.
    Snow, S.
    Fung, A. S.
    Dawe, D.
    Cheung, W. Y.
    Agulnik, J.
    Yan, M.
    Cohen, V.
    Wheatley-Price, P.
    Ho, C.
    Lok, B. H.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S542 - S542
  • [39] Prognostic Factors in Extensive Disease (ED) Small Cell Lung Cancer (SCLC): An ELCWP Phase III Randomized Trial
    Berghmans, Thierry
    Lafitte, Jean -Jacques
    Meert, Anne -Pascale
    Scherpereel, Arnaud
    Paesmans, Marianne
    Leclercq, Nathalie
    Sculier, Jean-Paul
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S721 - S721
  • [40] Prognostic factors in small cell lung cancer
    Torun, Elif
    Fidan, Ali
    Caglayan, Benan
    Salepci, Taflan
    Mayadagli, Alpaslan
    Salepci, Banu
    TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2008, 56 (01): : 22 - 29
12345